| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_chr1_0871900 | Intergenic-Intergenic | chr1:41641692-41641940 | chr1:41176020-41176268 | 249 nt | 0.3373 |
| hsa_SCMH1_0013400 | Intron-Intron | chr1:41647744-41648541 | chr1:41182072-41182869 | 798 nt | 0.4148 |
| hsa_SCMH1_0013500 | Intron-Exon-Intron | chr1:41650236-41651922 | chr1:41184564-41186250 | 1687 nt | 0.3942 |
| hsa_SCMH1_0013600 | Intron-Exon-Intron | chr1:41651573-41694649 | chr1:41185901-41228977 | 250 nt | 0.3360 |
| hsa_SCMH1_0013900 | Intron-Exon-Intron | chr1:41651793-41658572 | chr1:41186121-41192900 | 250 nt | 0.3360 |
| hsa_SCMH1_0014000 | Intron-Exon-Intron | chr1:41651793-41660798 | chr1:41186121-41195126 | 250 nt | 0.3760 |
| hsa_SCMH1_0014300 | Intron-Exon-Intron | chr1:41651793-41668919 | chr1:41186121-41203247 | 195 nt | 0.3641 |
| hsa_SCMH1_0014400 | Intron-Exon-Intron | chr1:41651793-41670212 | chr1:41186121-41204540 | 130 nt | 0.4154 |
| hsa_SCMH1_0014500 | Intron-Exon-Intron | chr1:41651793-41678544 | chr1:41186121-41212872 | 230 nt | 0.3739 |
| hsa_SCMH1_0014100 | Intron-Exon-Intron | chr1:41651793-41679220 | chr1:41186121-41213548 | 250 nt | 0.3600 |
A study in humans demonstrated that the circSCMH1 is significantly decreased in the plasma of patients with acute ischemic stroke and is significant in predicting stroke outcomes [Wei et al. DOI:10.1186/s12883-021-02397-0]. A study in mice demonstrated that exosomes from adipose-derived stem cells delivering the circSCMH1 reduced nerve damage by promoting microglial M2 polarization [Li et al. DOI:10.1016/j.neuint.2023.105643].